Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma

Renal cell carcinoma is the third most common urological cancer. Despite recent advances, late diagnosis and poor prognosis of advanced-stage disease remain a major problem, entailing the need for novel early diagnosis tools. Liquid biopsies represent a promising minimally invasive clinical tool, pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: José Pedro Sequeira, Vera Constâncio, João Lobo, Rui Henrique, Carmen Jerónimo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d0bff859876a4b40abd76ec2c117efb4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d0bff859876a4b40abd76ec2c117efb4
record_format dspace
spelling oai:doaj.org-article:d0bff859876a4b40abd76ec2c117efb42021-11-11T15:26:26ZUnveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma10.3390/cancers132152522072-6694https://doaj.org/article/d0bff859876a4b40abd76ec2c117efb42021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5252https://doaj.org/toc/2072-6694Renal cell carcinoma is the third most common urological cancer. Despite recent advances, late diagnosis and poor prognosis of advanced-stage disease remain a major problem, entailing the need for novel early diagnosis tools. Liquid biopsies represent a promising minimally invasive clinical tool, providing real-time feedback of tumor behavior and biological potential, addressing its clonal evolution and representing its heterogeneity. In particular, the study of circulating microRNAs and exosomal microRNAs in liquid biopsies experienced an exponential increase in recent years, considering the potential clinical utility and available technology that facilitates implementation. Herein, we provide a systematic review on the applicability of these biomarkers in the context of renal cell carcinoma. Issues such as additional benefit from extracting microRNAs transported in extracellular vesicles, use for subtyping and representation of different histological types, correlation with tumor burden, and prediction of patient outcome are also addressed. Despite the need for more conclusive research, available data indicate that exosomal microRNAs represent a robust minimally invasive biomarker for renal cell carcinoma. Thus, innovative research on microRNAs and novel detection techniques are likely to provide clinically relevant biomarkers, overcome current clinical challenges, and improve patient management.José Pedro SequeiraVera ConstâncioJoão LoboRui HenriqueCarmen JerónimoMDPI AGarticlerenal cell carcinomabiomarkersliquid biopsiesmicroRNAextracellular vesiclesexosomesNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5252, p 5252 (2021)
institution DOAJ
collection DOAJ
language EN
topic renal cell carcinoma
biomarkers
liquid biopsies
microRNA
extracellular vesicles
exosomes
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle renal cell carcinoma
biomarkers
liquid biopsies
microRNA
extracellular vesicles
exosomes
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
José Pedro Sequeira
Vera Constâncio
João Lobo
Rui Henrique
Carmen Jerónimo
Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
description Renal cell carcinoma is the third most common urological cancer. Despite recent advances, late diagnosis and poor prognosis of advanced-stage disease remain a major problem, entailing the need for novel early diagnosis tools. Liquid biopsies represent a promising minimally invasive clinical tool, providing real-time feedback of tumor behavior and biological potential, addressing its clonal evolution and representing its heterogeneity. In particular, the study of circulating microRNAs and exosomal microRNAs in liquid biopsies experienced an exponential increase in recent years, considering the potential clinical utility and available technology that facilitates implementation. Herein, we provide a systematic review on the applicability of these biomarkers in the context of renal cell carcinoma. Issues such as additional benefit from extracting microRNAs transported in extracellular vesicles, use for subtyping and representation of different histological types, correlation with tumor burden, and prediction of patient outcome are also addressed. Despite the need for more conclusive research, available data indicate that exosomal microRNAs represent a robust minimally invasive biomarker for renal cell carcinoma. Thus, innovative research on microRNAs and novel detection techniques are likely to provide clinically relevant biomarkers, overcome current clinical challenges, and improve patient management.
format article
author José Pedro Sequeira
Vera Constâncio
João Lobo
Rui Henrique
Carmen Jerónimo
author_facet José Pedro Sequeira
Vera Constâncio
João Lobo
Rui Henrique
Carmen Jerónimo
author_sort José Pedro Sequeira
title Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
title_short Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
title_full Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
title_fullStr Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
title_full_unstemmed Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
title_sort unveiling the world of circulating and exosomal micrornas in renal cell carcinoma
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d0bff859876a4b40abd76ec2c117efb4
work_keys_str_mv AT josepedrosequeira unveilingtheworldofcirculatingandexosomalmicrornasinrenalcellcarcinoma
AT veraconstancio unveilingtheworldofcirculatingandexosomalmicrornasinrenalcellcarcinoma
AT joaolobo unveilingtheworldofcirculatingandexosomalmicrornasinrenalcellcarcinoma
AT ruihenrique unveilingtheworldofcirculatingandexosomalmicrornasinrenalcellcarcinoma
AT carmenjeronimo unveilingtheworldofcirculatingandexosomalmicrornasinrenalcellcarcinoma
_version_ 1718435337093513216